Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakae Tanaka

Showing results (21-30 of 913) with videos related to

Pageof 92
Sort By:
Clinical Calcium|February 3, 2012
[Biomarker of bone destruction]Yuichi Nagase, Sakae Tanaka
Clinical Calcium|November 27, 2015
[Trends in orthopaedic surgery for patients with rheumatoid arthritis]Takumi Matsumoto, Sakae Tanaka
Journal of Bone and Mineral Metabolism|December 17, 2020
Correction to: RANKL as a therapeutic target of rheumatoid arthritisSakae Tanaka, Yoshiya Tanaka
Clinical Calcium|March 1, 2019
[The sequential therapy of romosozumab followed by denosumab for osteoporosis.]Kumiko Ono, Sakae Tanaka
Clinical Calcium|August 5, 2011
[RANKL/RANK signaling in rheumatoid arthritis]Yasunori Omata, Sakae Tanaka
Clinical Calcium|February 4, 2011
[Animal models for bone and joint disease. CIA, CAIA model]Jun Hirose, Sakae Tanaka
Clinical Calcium|October 5, 2010
[Cytokines in bone diseases. Genetic disorders of RANKL-RANK-OPG system]Naoto Tokuyama, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[Mechanism of the bone destruction in rheumatoid arthritis]Masaki Nakamura, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis]Atsuhiko Hikita, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2006
[Osteopetrosis]Yuichi Nagase, Sakae Tanaka
Pageof 92

Showing results (21-30 of 913) with videos related to

Sort By:
Pageof 92
Clinical Calcium|February 3, 2012
[Biomarker of bone destruction]Yuichi Nagase, Sakae Tanaka
Clinical Calcium|November 27, 2015
[Trends in orthopaedic surgery for patients with rheumatoid arthritis]Takumi Matsumoto, Sakae Tanaka
Journal of Bone and Mineral Metabolism|December 17, 2020
Correction to: RANKL as a therapeutic target of rheumatoid arthritisSakae Tanaka, Yoshiya Tanaka
Clinical Calcium|March 1, 2019
[The sequential therapy of romosozumab followed by denosumab for osteoporosis.]Kumiko Ono, Sakae Tanaka
Clinical Calcium|August 5, 2011
[RANKL/RANK signaling in rheumatoid arthritis]Yasunori Omata, Sakae Tanaka
Clinical Calcium|February 4, 2011
[Animal models for bone and joint disease. CIA, CAIA model]Jun Hirose, Sakae Tanaka
Clinical Calcium|October 5, 2010
[Cytokines in bone diseases. Genetic disorders of RANKL-RANK-OPG system]Naoto Tokuyama, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[Mechanism of the bone destruction in rheumatoid arthritis]Masaki Nakamura, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis]Atsuhiko Hikita, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 5, 2006
[Osteopetrosis]Yuichi Nagase, Sakae Tanaka
Pageof 92